mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
BRD-A02303741 |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.4 |
mRNA |
JQ-1 |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.4 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.4 |
mRNA |
SR1001 |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.4 |
mRNA |
nakiterpiosin |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
erastin |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
PF-4800567 hydrochloride |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.4 |